Finch Therapeutics Group, Inc. (FNCH)

OTCMKTS: FNCH · Delayed Price · USD

1.370

+0.150 (12.30%)

Jul 2, 2024, 2:44 PM EDT - Market closed

Finch Therapeutics Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-74.75	-113.7	-55.86	-39.25	-20.41
Depreciation & Amortization	1.52	5.51	2.3	0.79	0.48
Share-Based Compensation	1.93	7.84	4.16	3.1	0.61
Other Operating Activities	39.8	25.5	-17.74	4.03	2
Operating Cash Flow	-31.51	-74.85	-67.13	-31.33	-17.32
Capital Expenditures	0	-2.18	-15.98	-2.63	-1.01
Acquisitions	1.33	0	0.06	0	0.03
Investing Cash Flow	1.33	-2.18	-15.92	-2.63	-0.97
Common Stock Issued	0	0.29	118.58	0.06	0.15
Share Repurchases	0	0	0	0	-0.25
Other Financing Activities	-16.16	14.58	0.53	91.42	52.91
Financing Cash Flow	-16.16	14.87	119.11	91.48	53.3
Net Cash Flow	-45.91	-62.16	36.06	57.51	35.01
Free Cash Flow	-31.51	-77.03	-83.12	-33.96	-18.33
Free Cash Flow Margin	-29443.93%	-8946.92%	-448.50%	-439.98%	-180.47%
Free Cash Flow Per Share	-19.63	-48.46	-52.48	-21.11	-11.39

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.